• Gates, Merck and Novartis-backed Adjuvant Capital raises $300M for neglected diseases

    15 days ago - By Fierce Biotech

    Gates, Merck and Novartis-backed Adjuvant Capital raises $300M for neglected diseases badams
    Thu, 02/18/2021 - 05:44
    Read more ...